TABLE OF CONTENTS
1 INTRODUCTION 36
1.1 OBJECTIVES OF THE STUDY 36
1.2 MARKET DEFINITION 36
1.3 OVERVIEW OF THE GLOBAL RADIOTHERAPY MARKET 36
1.4 CURRENCY AND PRICING 38
1.5 LIMITATIONS 38
1.6 MARKETS COVERED 38
2 MARKET SEGMENTATION 41
2.1 MARKETS COVERED 41
2.2 GEOGRAPHICAL SCOPE 42
2.3 YEARS CONSIDERED FOR THE STUDY 43
2.4 DBMR TRIPOD DATA VALIDATION MODEL 44
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 47
2.6 MULTIVARIATE MODELLING 48
2.7 PRODUCT AND SERVICES SEGMENT LIFELINE CURVE 49
2.8 MARKET END USERS COVERAGE GRID 50
2.9 DBMR MARKET POSITION GRID 51
2.10 VENDOR SHARE ANALYSIS 52
2.11 SECONDARY SOURCES 53
2.12 ASSUMPTIONS 53
3 EXECUTIVE SUMMARY 54
4 PREMIUM INSIGHTS 56
4.1 PESTLE ANALYSIS 59
4.2 PORTER’S FIVE FORCES MODEL 60
4.3 PRICING ANALYSIS 61
5 REGULATORY GUIDELINES FOR RADIOTHERAPY 63
6 MARKET OVERVIEW 66
6.1 DRIVERS 68
6.1.1 GROWING PREVALENCE OF CANCER DISEASE 68
6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT 68
6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES 69
6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES 69
6.2 RESTRAINTS 69
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 69
6.2.2 HIGH COST OF TREATMENT AND RADIOTHERAPY PROCEDURE 70
6.3 OPPORTUNITIES 70
6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT 70
6.3.2 GROWING GOVERNMENT INITIATIVES TOWARD CANCER TREATMENT 71
6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT 72
6.4 CHALLENGES 72
6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS 72
6.4.2 RISK OF RADIATION EXPOSURE 73
7 GLOBAL RADIOTHERAPY MARKET, BY PRODUCT & SERVICES 74
7.1 OVERVIEW 75
7.2 SERVICES 77
7.3 PRODUCT 77
7.4 SOFTWARE 77
8 GLOBAL RADIOTHERAPY MARKET, BY TYPE 78
8.1 OVERVIEW 79
8.2 EXTERNAL-BEAM RADIATION THERAPY 81
8.3 INTERNAL RADIATION THERAPY 81
8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS 81
8.5 OTHERS 81
9 GLOBAL RADIOTHERAPY MARKET, BY APPLICATION 82
3.1 OVERVIEW 83
9.1 BREAST CANCER 86
9.2 LUNG CANCER 86
9.3 PROSTATE CANCER 86
9.4 COLORECTAL CANCER 86
9.5 LYMPHOMA 86
9.6 LIVER CANCER 86
9.7 THYROID CANCER 86
9.8 BRAIN CANCER 86
9.9 CERVICAL CANCER 87
9.10 SPINE CANCER 87
9.11 OTHERS 87
10 GLOBAL RADIOTHERAPY MARKET, BY END USER 88
10.1 OVERVIEW 89
10.2 HOSPITALS 91
10.3 RADIATION THERAPY CENTERS 91
10.4 SPECIALTY CLINICS 91
10.5 OTHERS 91
11 GLOBAL RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL 92
11.1 OVERVIEW 93
11.2 DIRECT TENDERS 95
11.3 THIRD PARTY DISTRIBUTORS 95
11.4 OTHERS 95
12 GLOBAL RADIOTHERAPY MARKET, BY REGION 96
12.1 OVERVIEW 97
12.2 NORTH AMERICA 102
12.3 EUROPE 123
12.4 ASIA-PACIFIC 185
12.5 CHINA 252
12.6 SOUTH AMERICA 258
12.7 MIDDLE EAST AND AFRICA 274
13 GLOBAL RADIOTHERAPY MARKET: COMPANY LANDSCAPE 326
13.1 COMPANY SHARE ANALYSIS: GLOBAL 326
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 327
13.3 COMPANY SHARE ANALYSIS: EUROPE 328
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 329
14 SWOT ANALYSIS 330
15 COMPANY PROFILE 331
15.1 SIEMENS HEALTHCARE GMBH 331
15.1.1 COMPANY SNAPSHOT 331
15.1.2 REVENUE ANALYSIS 331
15.1.3 COMPANY SHARE ANALYSIS 332
15.1.4 PRODUCT PORTFOLIO 332
15.1.5 RECENT DEVELOPMENT 332
15.2 ELEKTA 333
15.2.1 COMPANY SNAPSHOT 333
15.2.2 REVENUE ANALYSIS 333
15.2.3 COMPANY SHARE ANALYSIS 334
15.2.4 PRODUCT PORTFOLIO 334
15.2.5 RECENT DEVELOPMENTS 334
15.3 GENERAL ELECTRIC COMPANY 335
15.3.1 COMPANY SNAPSHOT 335
15.3.2 REVENUE ANALYSIS 335
15.3.3 COMPANY SHARE ANALYSIS 336
15.3.4 PRODUCT PORTFOLIO 336
15.3.5 RECENT DEVELOPMENT 336
15.4 HITACHI, LTD. 337
15.4.1 COMPANY SNAPSHOT 337
15.4.2 REVENUE ANALYSIS 337
15.4.3 PRODUCT PORTFOLIO 338
15.4.4 RECENT DEVELOPMENT 338
15.5 KONINKLIJKE PHILIPS N.V. 339
15.5.1 COMPANY SNAPSHOT 339
15.5.2 REVENUE ANALYSIS 339
15.5.3 COMPANY SHARE ANALYSIS 340
15.5.4 PRODUCT PORTFOLIO 340
15.5.5 RECENT DEVELOPMENT 340
15.6 ACCURACY INCORPORATED 341
15.6.1 COMPANY SNAPSHOT 341
15.6.2 REVENUE ANALYSIS 341
15.6.3 PRODUCT PORTFOLIO 342
15.6.4 RECENT DEVELOPMENT 342
15.7 BEBIG MEDICAL. 343
15.7.1 COMPANY SNAPSHOT 343
15.7.2 PRODUCT PORTFOLIO 343
15.7.3 RECENT DEVELOPMENT 343
15.8 BRAINLAB AG 344
15.8.1 COMPANY SNAPSHOT 344
15.8.2 PRODUCT PORTFOLIO 344
15.8.3 RECENT DEVELOPMENTS 344
15.9 CANON MEDICAL SYSTEMS CORPORATION 345
15.9.1 COMPANY SNAPSHOT 345
15.9.2 REVENUE ANALYSIS 345
15.9.3 PRODUCT PORTFOLIO 346
15.9.4 RECENT DEVELOPMENT 346
15.10 ECKERT & ZIEGLER BEBIG 347
15.10.1 COMPANY SNAPSHOT 347
15.10.2 REVENUE ANALYSIS 347
15.10.3 PRODUCT PORTFOLIO 348
15.10.4 RECENT DEVELOPMENT 348
15.11 IBA WORLDWIDE 349
15.11.1 COMPANY SNAPSHOT 349
15.11.2 REVENUE ANALYSIS 349
15.11.3 PRODUCT PORTFOLIO 350
15.11.4 RECENT DEVELOPMENT 350
15.12 LINATECH INC 351
15.12.1 COMPANY SNAPSHOT 351
15.12.2 PRODUCT PORTFOLIO 351
15.12.3 RECENT DEVELOPMENT 351
15.13 MEVION MEDICAL SYSTEMS 352
15.13.1 COMPANY SNAPSHOT 352
15.13.2 PRODUCT PORTFOLIO 352
15.13.3 RECENT DEVELOPMENT 352
15.14 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH) 353
15.14.1 COMPANY SNAPSHOT 353
15.14.2 PRODUCT PORTFOLIO 353
15.14.3 RECENT DEVELOPMENT 353
15.15 P-CURE 354
15.15.1 COMPANY SNAPSHOT 354
15.15.2 PRODUCT PORTFOLIO 354
15.15.3 RECENT DEVELOPMENT 354
15.16 SHINVA MEDICAL INSTRUMENT CO., LTD. 355
15.16.1 COMPANY SNAPSHOT 355
15.16.2 PRODUCT PORTFOLIO 355
15.16.3 RECENT DEVELOPMENT 355
15.17 UNITED IMAGING HEALTHCARE CO., LTD 356
15.17.1 COMPANY SNAPSHOT 356
15.17.2 PRODUCT PORTFOLIO 356
15.17.3 RECENT DEVELOPMENT 356
15.18 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”) 357
15.18.1 COMPANY SNAPSHOT 357
15.18.2 REVENUE ANALYSIS 357
15.18.3 PRODUCT PORTFOLIO 358
15.18.4 RECENT DEVELOPMENT 358
15.19 ZEISS INTERNATIONAL 359
15.19.1 COMPANY SNAPSHOT 359
15.19.2 REVENUE ANALYSIS 359
15.19.3 COMPANY SHARE ANALYSIS 360
15.19.4 PRODUCT PORTFOLIO 360
15.19.5 RECENT DEVELOPMENT 360
16 QUESTIONNAIRE 361
17 RELATED REPORTS 365
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
